SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040388
Filing Date
2019-11-05
Accepted
2019-11-05 16:14:57
Documents
58
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atrs-10q_20190930.htm 10-Q 1713726
2 EX-31.1 atrs-ex311_10.htm EX-31.1 15742
3 EX-31.2 atrs-ex312_11.htm EX-31.2 15775
4 EX-32.1 atrs-ex321_15.htm EX-32.1 6478
5 EX-32.2 atrs-ex322_12.htm EX-32.2 6489
  Complete submission text file 0001564590-19-040388.txt   5868348

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atrs-20190930.xml EX-101.INS 1216172
7 XBRL TAXONOMY EXTENSION SCHEMA atrs-20190930.xsd EX-101.SCH 42403
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atrs-20190930_cal.xml EX-101.CAL 48058
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atrs-20190930_def.xml EX-101.DEF 137119
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20190930_lab.xml EX-101.LAB 366527
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20190930_pre.xml EX-101.PRE 271257
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32302 | Film No.: 191193464
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences